OPTISONE DIN 00528447
Status: Cancelled Post Market
Holder: EVSCO PHARMACEUTICAL, DIVISION OF VÉTOQUINOL U.S.A.
Molecule: PREDNISOLONE
Health Canada record
| Active ingredient(s) | PREDNISOLONE 2 MG; NEOMYCIN 3.5 MG |
|---|---|
| Dosage form | Ointment |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1985 |
| Current status date | 18-Jul-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PREDNISOLONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00021679 | NOVO-PREDNISOLONE 5MG | NOVOPHARM LIMITED | Tablet | PREDNISOLONE 5 MG | Cancelled Post Market |
| 00153915 | PRED C TAB | ORMOND VETERINARY SUPPLY LTD. | Tablet | PREDNISOLONE 1 MG; SALICYLAMIDE 325 MG; ASCORBIC ACID 25 MG; ALUMINUM HYDROXIDE 35 MG | Cancelled Post Market |
| 00224693 | PREDNISIZE SOLUTION | GERMIPHENE CORPORATION | Solution | PREDNISOLONE 1 %; CRESYL ACETATE 25 %; PARACHLOROPHENOL 25 %; CAMPHOR 50 % | Cancelled Post Market |
| 00493716 | VETALONE 50 INJ 50MG/ML | VETCOM 1979 INC. | Suspension | PREDNISOLONE 50 MG | Cancelled Post Market |
International API supply for PREDNISOLONE
6 valid EDQM Certificates of Suitability from 6 holders. 49 active FDA Drug Master Files.
Request a quote for OPTISONE